The process for drug approval by the MFDS involves several stages. It begins with preclinical testing, followed by clinical trials. Data from these are then submitted for review. The MFDS evaluates the drug's safety, efficacy, and quality before granting approval. Post-approval monitoring ensures ongoing safety assessment. Finally, the drug can be marketed to the public.